Radke Susanne, Chander Harish, Schäfer Patrick, Meiss Gregor, Krüger Rejko, Schulz Jörg B, Germain Doris
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA.
J Biol Chem. 2008 May 9;283(19):12681-5. doi: 10.1074/jbc.C800036200. Epub 2008 Mar 24.
We report here that blocking the activity of the 26 S proteasome results in drastic changes in the morphology of the mitochondria and accumulation of intermembrane space (IMS) proteins. Using endonuclease G (endoG) as a model IMS protein, we found that accumulation of wild-type but to a greater extent mutant endoG leads to changes in the morphology of the mitochondria similar to those observed following proteasomal inhibition. Further, we show that wild-type but to a greater extent mutant endoG is a substrate for ubiquitination, suggesting the presence of a protein quality control. Conversely, we also report that wild-type but not mutant endoG is a substrate for the mitochondrial protease Omi but only upon inhibition of the proteasome. These findings suggest that although elimination of mutant IMS proteins is strictly dependent on ubiquitination, elimination of excess or spontaneously misfolded wild-type IMS proteins is monitored by ubiquitination and as a second checkpoint by Omi cleavage when the proteasome function is deficient. One implication of our finding is that in the context of attenuated proteasomal function, accumulation of IMS proteins would contribute to the collapse of the mitochondrial network such as that observed in neurodegenerative diseases. Another implication is that such collapse could be accelerated either by mutations in IMS proteins or by mutations in Omi itself.
我们在此报告,阻断26S蛋白酶体的活性会导致线粒体形态发生剧烈变化以及膜间隙(IMS)蛋白的积累。以内切核酸酶G(endoG)作为模型IMS蛋白,我们发现野生型但在更大程度上是突变型endoG的积累会导致线粒体形态发生变化,类似于蛋白酶体抑制后观察到的变化。此外,我们表明野生型但在更大程度上是突变型endoG是泛素化的底物,这表明存在蛋白质质量控制。相反,我们还报告野生型但不是突变型endoG是线粒体蛋白酶Omi的底物,但仅在蛋白酶体受到抑制时才是。这些发现表明,虽然突变型IMS蛋白的消除严格依赖于泛素化,但当蛋白酶体功能不足时,过量或自发错误折叠的野生型IMS蛋白的消除则通过泛素化监测,并作为第二个检查点通过Omi切割进行监测。我们发现的一个含义是,在蛋白酶体功能减弱的情况下,IMS蛋白的积累将导致线粒体网络的崩溃,如在神经退行性疾病中观察到的那样。另一个含义是,这种崩溃可能会因IMS蛋白的突变或Omi自身的突变而加速。